doi: 10.3389/fendo.2022.1043789 108 WhartonSDaviesMDickerDLingvayIMosenzonORubinoDMet al
In February 2025, the Food and Drug Administration stated that nationwide shortages of the most popular GLP-1 drugs had resolved
Tumor-targeting albumin nanoparticles as an efficacious drug delivery system and potential diagnostic tool in non-muscle-invasive bladder cancer therapy
Trusted healthcare supply channels support reliable injection materials for daily care
That origin story explains the evidence gap: one compound accumulated regulated trial data, the other accumulated forum anecdotes and, in the medical literature, adverse-event case reports
It is likely to be the fifth most common cause of death, following an 8% attribution to the mortality rate in the USA, Canada, and the Middle East [105]